Grzegorz Warzecha
Greg Warzecha is a Polish entrepreneur and deep learning expert with over a decade of experience in artificial intelligence (AI). He is the founder and CEO of Genotic, a biotechnology startup that leverages AI to revolutionize antibody development. Genotic's platform utilizes advanced deep learning algorithms to identify new antibodies faster than traditional methods, and with guaranteed high specificity. This approach enables rapid development of targeted antibodies for various applications. Prior to establishing Genotic, Warzecha co-founded User.com, a marketing automation platform. Under his leadership, User.com expanded its services to over 340 clients, including brands such as Carrefour, BNP Paribas, and LG Electronics. The platform's success culminated in its acquisition in 2023, underscoring Warzecha's ability to scale technological solutions effectively.Greg Warzecha leverages his extensive experience in deep learning and AI to drive Genotic's innovative approach, demonstrating the transformative potential of AI in accelerating scientific development.
Genotic
Machine Learning and AI Tools to Guide Engineering of Human Therapeutics
-
Join us for an in-depth look at how biotechnology leaders are harnessing machine learning and data-driven approaches to engineer novel human therapeutics right now—well beyond the “someday” promises of AI. In this session, experts from pioneering organizations will share real-world insights into using big data and advanced analytics to accelerate everything from target discovery to clinical development. Discover how these teams are unlocking fresh possibilities for personalized treatments, improving success rates, and shaping the future of human health through powerful, actionable applications of ML and AI.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
